Try our Advanced Search for more refined results
July 01, 2010
CELGENE CORPORATION et al v. SUN PHARMACEUTICAL INDUSTRIES, INC.
Case Number:
2:10-cv-03378
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 14, 2011
Novartis, Sun Settle IP Suit Over Generic Focalin
Novartis Pharma AG resolved a patent infringement suit Monday in New Jersey over Sun Pharmaceutical Industries Ltd.'s proposed generic version of Novartis' attention deficit disorder drug Focalin after receiving government approval of a settlement agreement.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login